Oral bioavailability of AOD-9604 has not been formally quantified in humans
BPC-157: NO system modulation, VEGF/FGF-2 upregulation, FAK-paxillin pathway, gastric juice stability GHK-Cu: Cu2+-dependent gene regulation (~4,000 genes), TGF-beta signaling, collagen/decorin synthesis, SOD/catalase induction BPC-157: No metal cofactor required activity is sequence-dependent GHK-Cu: Copper stoichiometry (1:1) is essential apo-GHK shows reduced bioactivity BPC-157 Research Areas: Gut & Tendon Studies The majority of BPC-157 research originates from a single laboratory group (Sikiric et al., University of Zagreb), which has published extensively on its effects in rodent models
Decision factors include evidence strength, legal status, and cost range [$30 to $120]
Developing and testing a new drug is expensive, and companies count on recouping their costs by having, in effect, a monopoly on the market for a new drug
I wish the weight loss meds could be more affordable Thank you Only been on this a month so far
